Site updated at Wednesday, 22 June 2016

Living with Dementia

Immune Globulin

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   

Alzheimer’s Disease

mcr1 - vitamin b-11 - department of psychiatry and psychotherapy1 - lewy body disease1 - genomic dna1 - world alzheimers day1 - dementia cases2 - obstructive lung disease1 - risk factors1 - down syndrome2 - cardiovascular risk factors1 - rem-sleep behavior disorder1 - pd dementia1 - coffee2 - risperidone2 - rigidity1 - aricept1 - treat alzheimer's1 - memory lapses2 - familial alzheimer's disease2 - nerve cell1 - ad risk factors1 - tavi2 - diagnosing alzheimer's disease1 - cognitive1 - memory loss20 - early dementia1 - stepfamily1 - long-term memory1 - mri scan1 -